Next Article in Journal
Hippocampal Proteome of Rats Subjected to the Li-Pilocarpine Epilepsy Model and the Effect of Carisbamate Treatment
Next Article in Special Issue
Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System
Previous Article in Journal
5-aza-2′,2′-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
Previous Article in Special Issue
Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessArticle
Pharmaceuticals 2017, 10(3), 66;

Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards

Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA
U.S. Pharmacopeia, Rockville, MD 20852, USA
Center for Scientific Review, National Institutes of Health, Bethesda, MD 20892, USA
Author to whom correspondence should be addressed.
Received: 1 May 2017 / Revised: 6 July 2017 / Accepted: 19 July 2017 / Published: 22 July 2017
(This article belongs to the Special Issue Glycosaminoglycans and Proteoglycans)
Full-Text   |   PDF [2419 KB, uploaded 22 July 2017]   |  


Enoxaparin is a low-molecular weight heparin used to treat thrombotic disorders. Following the fatal contamination of the heparin supply chain in 2007–2008, the U.S. Pharmacopeia (USP) and U.S. Food and Drug Administration (FDA) have worked extensively to modernize the unfractionated heparin and enoxaparin monographs. As a result, the determination of molecular weight (MW) has been added to the monograph as a measure to strengthen the quality testing and to increase the protection of the global supply of this life-saving drug. The current USP calibrant materials used for enoxaparin MW determination are composed of a mixture of oligosaccharides; however, they are difficult to reproduce as the calibrants have ill-defined structures due to the heterogeneity of the heparin parent material. To address this issue, we describe a promising approach consisting of a predictive computational model built from a library of chemoenzymatically synthesized heparin oligosaccharides for enoxaparin MW determination. Here, we demonstrate that this test can be performed with greater efficiency by coupling synthetic oligosaccharides with the power of computational modeling. Our approach is expected to improve the MW measurement for enoxaparin. View Full-Text
Keywords: enoxaparin; USP; MW determination; oligosaccharide calibrants; computational modeling; HPLC; compendial test enoxaparin; USP; MW determination; oligosaccharide calibrants; computational modeling; HPLC; compendial test

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

Printed Edition Available!
A printed edition of this Special Issue is available here.

Share & Cite This Article

MDPI and ACS Style

Arnold, K.M.; Capuzzi, S.J.; Xu, Y.; Muratov, E.N.; Carrick, K.; Szajek, A.Y.; Tropsha, A.; Liu, J. Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards. Pharmaceuticals 2017, 10, 66.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top